Shares of Becton Dickinson & Co. BDX slipped 1.11% to $224.92 Tuesday, on what proved to be an all-around grim trading ...

The stock's rise snapped a four-day losing streak.

Medical-device maker Becton Dickinson and Co. accused a former area sales director of bolting to a competitor in violation of ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report)’s stock price fell 0.3% during trading on Thursday following insider selling activity. The company traded as low as $222.01 and last traded ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold ...

Learn more about whether Becton, Dickinson and Company or GE HealthCare Technologies Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

A new study found that 9.1% of medical device AEs were reported to the FDA 180 days later than required over a three-year ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Tuesday, 11 March 2025, Becton Dickinson (NYSE: BDX) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic focus on separating its Life Sciences business ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Citi analyst Joanne Wuensch reiterated a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed yesterday at ...

My monthly update and commentary on the top dividend stock picks sourced from Barron's, March 2025 edition. Standout choices ...